BRINGING YOU INFORMATION.  PROVIDING YOU A PLATFORM.

 

 
THE PHARMA REVIEW (MARCH - APRIL 2011)

The Indian Biotechnology Sector - A Review

1Alok Kumar Sengupta, 2Kshitij Sen Chaudhary

Abstract: The Indian Biotechnology sector is one of the much talked about topic these days and has fueled the overall healthcare and applied sciences landscape in India. The Indian Biotechnology market is estimated at USD 3.2 billion (ranked # 12 at a global level), and is growing at +20% over 2008. The key sectors are Bio-pharmaceuticals (64% of total biotechnology market value), Bio-services (17% of total market), Bio-agriculture (14%), Bio-industry (3%), and Bio-informatics. The total biotechnology market is expected to exceed USD 7.0 billion by 2012 with a CAGR of 30% (2009-12) and bio-pharmaceuticals are expected to grow with 22% CAGR from 2009 to 2012.
From a regulatory and policy standpoint: the National Biotechnological Strategy 2009 has been approved by Government of India. The strategy while enabling full utilization of currently available opportunities in manufacturing and services will lay a strong foundation on discovery and innovation, effectively utilizing novel technology platforms to contribute to long term benefits in agriculture, animal productivity, human health, environmental security and sustainable industrial growth.
Overall this strategic framework is expected to have a positive impact on the biotechnology landscape and assist the growth. The changing policies have also enhanced the investment in the sector which was more than USD 600 million. The modifications in policies and regulatory landscape have created many "biotechnology clusters". India’s main bio-clusters are located in metro cities like Bangalore, Hyderabad, Pune-Mumbai and Ahmedabad-Vadodara. The clusters offer encouraging infrastructure for start-ups and entrepreneurs to invest in biotechnology and develop companies.
This report captures information on major players in biotechnology sector, key revenue and growth trend and success factors for such companies. Along with this a brief snapshot of key players has also been captured, Indian companies dominate the industry landscape with leading companies like BIOCON, SHANTHA BIOTECH (now a part of Sanofi-Aventis), etc. The key global biotechnology based companies in India are NOVOZYMES, NOVO NORDISK, ELI-LILY are based out of Denmark and USA. South Korean companies like LG Life Sciences India, DAEWOONG Pharmaceutical are also present in India.
An emerging trend has been interest of countries like China, Germany and Canada in Indian Biotechnology space. This is both from an industry as well as academia perspective. At an overall level Indian Biotechnology sector will see growing interest as policies get smooth a friendly coupled by the booming market.

Indian Biotechnology Market: An Overview
Indian Biotechnology Market comprises of specialized sectors and sub-markets like Bio-pharmaceuticals, Bio-services, Bio-agriculture, Bio-industry, and Bio-informatics. Before we proceed further it is imperative to define each segment in terms of value and growth potential. India contributes around 2% value of the global biotech industry. There are more than 325 biotechnology companies operating and employing more than 20,000 scientists, with active support from leading academic institutes and Universities the workforce dedicated to biotechnology is bound to grow. According to Industry estimates, India is ranked among top-12 biotechnology countries worldwide, and is the third biggest in Asia-Pacific in terms of number of biotech companies. The investments in this industry have been strong over the past few years and have reached at USD 637 million. The Indian Biotechnology Market is valued at USD 3,203 million and grew by 28% over 2008. The market is expected to exceed USD 7,000 million by 2012 with a CAGR of 30% (2009-2012). Bio-pharmaceuticals have a market share of 64% of overall market and are expected to grow with 22% CAGR from 2009 to 2012.The Indian Biotechnology industry was slow to start, but has been gaining momentum for the past couple of years. Although, the current share in the global biotech market is relatively low, but it has necessary potential to become a prominent player in the global arena1.

 

 

Go to Content Index Page

PHARMA REVIEW - ARTICLES ARCHIVE ( COMPLETE LIST)

 

The above content is an abstract only. For the full Article please contact:
KONGPOSH Publications Pvt. Ltd.
ICS House, C-19, Commercial Complex, SDA, Opp. IIT Gate, New Delhi, India -110016
Tel.: 26855839, 9811195411
Email: kongposhpub@gmail.com, Website: http://www.kppub.com

 
 
 
 

Copyright KONGPOSH PUBLICATIONS Pvt. Ltd.